Bit Capital Gmb H Bluebird Bio, Inc. Transaction History

Bit Capital Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2025	SELL	$1.32 - $4.83 $107,123 - $391,973	-81,154 Closed	0 $0
Q2 2023 Feb 12, 2025	BUY	$2.79 - $5.03 $128,769 - $232,154	46,154 Added 131.87%	81,154 $261 Million
Q1 2023 Feb 12, 2025	BUY	$3.14 - $8.22 $43,960 - $115,080	14,000 Added 66.67%	35,000 $110 Million
Q4 2022 Feb 12, 2025	SELL	$5.77 - $8.49 $230,799 - $339,600	-40,000 Reduced 65.57%	21,000 $144 Million
Q3 2022 Feb 12, 2025	SELL	$3.75 - $7.39 $39,562 - $77,964	-10,550 Reduced 14.74%	61,000 $348 Million
Q2 2022 Feb 12, 2025	BUY	$2.94 - $5.23 $210,357 - $374,206	71,550 New	71,550 $328 Million

49.8M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.